According to the Zhitong Finance APP, Layn (002166.SZ) announced that it has recently received a certification notice from the U.S. Food and Drug Administration (FDA). The company's Rebaudioside M2 (RebM2), produced through enzyme conversion, has officially passed the GRAS (Generally Recognized as Safe) certification and can be used as a food additive and dietary supplement.

The announcement stated that the RebM2 produced by the company's enzyme conversion method has obtained FDA GRAS certification, marking that the product's quality and safety have passed the strict review of the FDA, meeting the entry requirements for the U.S. food and beverage market. This not only helps in the in-depth promotion and sales of the product in the U.S. market but will also significantly enhance the differentiated competitiveness and overall strength of the company's core products, which is expected to have a very positive impact on the company's future development.

RebM2 is a high-quality rare monomer component among steviol glycosides, but the yield from traditional production methods cannot meet market demand, and the processes are complicated with high production costs. In contrast, the RebM2 produced by the company using enzyme conversion has significant advantages in efficiency, cost, and quality, not only meeting the market demand for high-performance sweeteners but also promoting the establishment and development of a sustainable production model through synthetic biology